Champions Oncology, Inc.CSBRNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR-23.2%
5Y CAGR+31.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-23.2%/yr
vs +71.1%/yr prior
5Y CAGR
+31.5%/yr
Recent deceleration
Acceleration
-94.3pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 220.35% |
| 2024 | -255.17% |
| 2023 | -39.13% |
| 2022 | 486.50% |
| 2021 | -157.87% |
| 2020 | 56.02% |
| 2019 | 251.88% |
| 2018 | 56.83% |
| 2017 | 55.98% |
| 2016 | 33.00% |